ロード中...
Current progress in searching for clinically useful biomarkers of blood–brain barrier damage following cerebral ischemia
Ischemic stroke is a leading cause of death and disability. Fear of intracranial hemorrhage (ICH) has been the primary reason for withholding tissue plasminogen activator (tPA) and thrombectomy, the only two widely accepted treatments for ischemic stroke. Thrombolysis treatment is only allowed in a...
保存先:
| 出版年: | Brain Circ |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6329218/ https://ncbi.nlm.nih.gov/pubmed/30693340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/bc.bc_11_18 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|